Export this record

Export record to excel

File type to download

Beta version

Select record 2

ArticlesPeer ReviewedFull Text

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Author / Creator:Dreno, Brigitte, Prof ; Thompson, John F, Prof ; Smithers, Bernard Mark, Prof ; Santinami, Mario, MD ; Jouary, Thomas, MD ; Gutzmer, Ralf, Prof ; Levchenko, Evgeny, MD ; Rutkowski, Piotr, Prof ; Grob, Jean-Jacques, Prof ; Korovin, Sergii, MD ; Drucis, Kamil, MD ; Grange, Florent, Prof ; Machet, Laurent, Prof ; Hersey, Peter, Prof ; Krajsova, Ivana, MD ; Testori, Alessandro, MD ; Conry, Robert, MD ; Guillot, Bernard, Prof ; Kruit, Wim H J, MD ; Demidov, Lev, Prof ; Thompson, John A, Prof ; Bondarenko, Igor, Prof ; Jaroszek, Jaroslaw, MD ; Puig, Susana, MD ; Cinat, Gabriela, MD ; Hauschild, Axel, Prof ; Goeman, Jelle J, Prof ; van Houwelingen, Hans C, Prof ; Ulloa-Montoya, Fernando, PhD ; Callegaro, Andrea, PhD ; Dizier, Benjamin, MPH ; Spiessens, Bart, PhD ; Debois, Muriel, MSc ; Brichard, Vincent G, MD ; Louahed, Jamila, PhD ; Therasse, Patrick, MD ; Debruyne, Channa, MD ; Kirkwood, John M, Prof

Publisher:England: Elsevier Ltd

Journal title:The lancet oncology, 2018-07, Vol.19 (7), p.916-929

View online as a Library member

Export record to excel

Export this record

Export record to excel

A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies

Export this record

Export record to excel

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Refine your search